Multiple Assemblies exist for SMTL entry 5vse
Structure of human G9a SET-domain (EHMT2) in complex with inhibitor 17: N~2~-cyclopentyl-6,7-dimethoxy-N~2~-methyl-N~4~-(1-methylpiperidin-4-yl)quinazoline-2,4-diamine; X-RAY DIFFRACTION 1.60 Å

	SMTL ID 5vse.1 Ligands ZINC ION; S-ADENOSYLMETHIONINE; N~2~-cyclopentyl-6,7-dimethoxy-N~2~-methyl-N~4~-(1-methylpiperidin-4-yl)quinazoline-2,4-diamine Polypeptides Histone-lysine N-methyltransferase EHMT2 Oligo-state monomer
	SMTL ID 5vse.2 Ligands ZINC ION; S-ADENOSYLMETHIONINE; N~2~-cyclopentyl-6,7-dimethoxy-N~2~-methyl-N~4~-(1-methylpiperidin-4-yl)quinazoline-2,4-diamine Polypeptides Histone-lysine N-methyltransferase EHMT2 Oligo-state monomer
	SMTL ID 5vse.3 Ligands ZINC ION; S-ADENOSYLMETHIONINE; N~2~-cyclopentyl-6,7-dimethoxy-N~2~-methyl-N~4~-(1-methylpiperidin-4-yl)quinazoline-2,4-diamine Polypeptides Histone-lysine N-methyltransferase EHMT2 Oligo-state homo-dimer